Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Fecal microbiota transplantation was originally introduced as a method to repair intestinal microbiota following failure of multiple treatments of recurrent Clostridium difficile infection with antibiotics. However, it is hypothesized that intestinal dysbiosis may contribute to the pathogenesis of many diseases, especially those involving the gastrointestinal tract. Therefore, fecal microbiota transplantation is increasingly being explored as a potential treatment that aims to optimize microbiota composition and functionality. Here, we review the current state of fecal microbiota transplantation development and applications in conditions of greatest interest to a gastroenterologist.

Original languageEnglish (US)
Pages (from-to)353-361
Number of pages9
JournalClinical Gastroenterology and Hepatology
Volume17
Issue number2
DOIs
StatePublished - Jan 2019

Keywords

  • Clostridium difficile Infection
  • Fecal Microbiota Transplantation
  • Inflammatory Bowel Disease
  • Irritable Bowel Syndrome
  • Liver Disease
  • Pathobiome

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint Dive into the research topics of 'Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease'. Together they form a unique fingerprint.

Cite this